Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal rod cell | 6 studies | 32% ± 17% | |
epithelial cell | 5 studies | 33% ± 9% | |
retinal cone cell | 3 studies | 37% ± 13% | |
ciliated cell | 3 studies | 25% ± 6% | |
glutamatergic neuron | 3 studies | 31% ± 6% | |
goblet cell | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 2195.33 | 966 / 966 | 100% | 51.12 | 527 / 527 |
prostate | 100% | 1244.23 | 245 / 245 | 100% | 27.07 | 502 / 502 |
esophagus | 100% | 1514.35 | 1443 / 1445 | 100% | 35.30 | 183 / 183 |
stomach | 100% | 1041.78 | 358 / 359 | 100% | 40.39 | 286 / 286 |
bladder | 100% | 864.10 | 21 / 21 | 100% | 29.52 | 502 / 504 |
brain | 100% | 1344.69 | 2636 / 2642 | 100% | 12.70 | 703 / 705 |
uterus | 99% | 638.16 | 169 / 170 | 100% | 21.71 | 459 / 459 |
breast | 100% | 759.93 | 459 / 459 | 99% | 23.07 | 1111 / 1118 |
thymus | 100% | 664.66 | 650 / 653 | 99% | 15.15 | 601 / 605 |
lung | 98% | 704.37 | 569 / 578 | 100% | 26.77 | 1155 / 1155 |
kidney | 100% | 977.84 | 89 / 89 | 98% | 14.37 | 879 / 901 |
pancreas | 97% | 567.07 | 319 / 328 | 99% | 27.81 | 177 / 178 |
adrenal gland | 100% | 1202.67 | 258 / 258 | 95% | 16.92 | 218 / 230 |
liver | 100% | 1255.94 | 225 / 226 | 95% | 13.01 | 386 / 406 |
ovary | 91% | 375.11 | 163 / 180 | 100% | 16.42 | 430 / 430 |
skin | 100% | 1378.53 | 1808 / 1809 | 90% | 13.45 | 424 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.18 | 29 / 29 |
spleen | 100% | 944.50 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.03 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.06 | 1 / 1 |
adipose | 100% | 798.06 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 917.45 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 91% | 474.18 | 781 / 861 | 0% | 0 | 0 / 0 |
muscle | 90% | 402.54 | 720 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 738.49 | 719 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 57% | 4.60 | 46 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008631 | Biological process | intrinsic apoptotic signaling pathway in response to oxidative stress |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0030111 | Biological process | regulation of Wnt signaling pathway |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0034237 | Molecular function | protein kinase A regulatory subunit binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0051018 | Molecular function | protein kinase A binding |
GO_0005515 | Molecular function | protein binding |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0019207 | Molecular function | kinase regulator activity |
Gene name | GSKIP |
Protein name | GSK3B interacting protein GSK3B-interacting protein (GSKIP) (GSK3beta interaction protein) |
Synonyms | C14orf129 HSPC210 |
Description | FUNCTION: A-kinase anchoring protein for GSK3B and PKA that regulates or facilitates their kinase activity towards their targets . The ternary complex enhances Wnt-induced signaling by facilitating the GSK3B- and PKA-induced phosphorylation of beta-catenin leading to beta-catenin degradation and stabilization respectively . Upon cAMP activation, the ternary complex contributes to neuroprotection against oxidative stress-induced apoptosis by facilitating the PKA-induced phosphorylation of DML1 and PKA-induced inactivation of GSK3B . During neurite outgrowth promotes neuron proliferation; while increases beta-catenin-induced transcriptional activity through GSK3B kinase activity inhibition, reduces N-cadherin level to promote cell cycle progression . . |
Accessions | ENST00000556095.5 ENST00000555181.6 G3V368 Q9P0R6 ENST00000553699.5 ENST00000438650.5 G3V4I5 ENST00000555757.1 ENST00000554182.5 |